EnBio Holdings Balance Sheet Health

Financial Health criteria checks 4/6

EnBio Holdings has a total shareholder equity of ¥9.3B and total debt of ¥9.7B, which brings its debt-to-equity ratio to 103.8%. Its total assets and total liabilities are ¥21.0B and ¥11.7B respectively. EnBio Holdings's EBIT is ¥1.2B making its interest coverage ratio 18.4. It has cash and short-term investments of ¥3.4B.

Key information

103.8%

Debt to equity ratio

JP¥9.67b

Debt

Interest coverage ratio18.4x
CashJP¥3.43b
EquityJP¥9.32b
Total liabilitiesJP¥11.67b
Total assetsJP¥20.99b

Recent financial health updates

No updates

Recent updates

EnBio Holdings (TSE:6092) Has Affirmed Its Dividend Of ¥8.00

Nov 16
EnBio Holdings (TSE:6092) Has Affirmed Its Dividend Of ¥8.00

Returns On Capital At EnBio Holdings (TSE:6092) Have Stalled

Aug 07
Returns On Capital At EnBio Holdings (TSE:6092) Have Stalled

Financial Position Analysis

Short Term Liabilities: 6092's short term assets (¥8.8B) exceed its short term liabilities (¥5.1B).

Long Term Liabilities: 6092's short term assets (¥8.8B) exceed its long term liabilities (¥6.6B).


Debt to Equity History and Analysis

Debt Level: 6092's net debt to equity ratio (67%) is considered high.

Reducing Debt: 6092's debt to equity ratio has reduced from 163.2% to 103.8% over the past 5 years.

Debt Coverage: 6092's debt is not well covered by operating cash flow (4%).

Interest Coverage: 6092's interest payments on its debt are well covered by EBIT (18.4x coverage).


Balance Sheet


Discover healthy companies